切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2010, Vol. 04 ›› Issue (05) : 588 -593. doi: 10.3877/cma.j.issn.1674-0807.2010.05.011

综述

细胞外基质蛋白1与乳腺癌的研究进展
吴秋婉1, 张志明1,()   
  1. 1.361003 福建厦门,福建医科大学教学医院厦门市第一医院乳腺外科
  • 收稿日期:2010-04-20 出版日期:2010-10-01
  • 通信作者: 张志明
  • 基金资助:
    厦门市卫生局科研基金(WSK0505)

Research progress of extracellular matrix protein 1 in breast cancer

Qiu-wan WU, Zhi-ming ZHANG()   

  • Received:2010-04-20 Published:2010-10-01
  • Corresponding author: Zhi-ming ZHANG
引用本文:

吴秋婉, 张志明. 细胞外基质蛋白1与乳腺癌的研究进展[J/OL]. 中华乳腺病杂志(电子版), 2010, 04(05): 588-593.

Qiu-wan WU, Zhi-ming ZHANG. Research progress of extracellular matrix protein 1 in breast cancer[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2010, 04(05): 588-593.

[1]
Mathieu E,Meheus L,Raymackers J,et al.Characterization of the osteogenic stromal cell line MN7:identification of secreted MN7 proteins using two-dimensional polyacrylamide gel electrophoresis,Western blotting and microsequencing.Bone Miner Res,1994,9:903-913.
[2]
Smits P,Ni J,Feng P,et al.The human extracellular matrix gene 1(ECM1):genomic structure,cDNA cloning,expression pattern and chromosomal localization.Genomics,1997,45:487-495.
[3]
Sercu S,Zhang M,Oyama N,et al.Interaction of extracellular matrix protein 1 with extracellular matrix components:ECM1 is a basement membrane protein of the skin.J Invest Dermato,2008,128:1397-1408.
[4]
Sander CS,Sercu S,Ziemer M,et al.Expression of extracellular matrix protein 1(ECM1)in human skin is decreased by age and increased upon ultraviolet exposure.Br J Dermatol,2006,2:218-224.
[5]
Smits P,Bhalerao J,Merregaert J.Molecular cloning and characterization of the mouse Ecm1 gene and its 5'regulatory sequences.Gene,1999,226:253-261.
[6]
Horev L,Potikha T,Ayalon S,et al.A novel splice site mutation in ECM-1gene in a consanguineous family with lipoid proteinosis.Exp Dermatol,2005,14:891-897.
[7]
Kawakami Y,Oyama N,Hanami Y,et al.A case of lichen sclerosus of the scalp associated with autoantibodies to extracellular matrix protein 1.Arch Dermatol,2009,145:1458-1460.
[8]
Uchida T,Hayashi H,Inaoki M,et al.A failure of mucocutaneous lymphangiogenesis may underlie the clinical features of lipoid proteinosis.Br J Dermatol,2007,156:152-157.
[9]
Han Z,Ni J,Smiths P,et al.Extracellular matrix protein 1(ECM1)has angiogenic properties and is expressed by breast tumor cells.FASEB J,2001,15:988-994.
[10]
Albig AR,Roy TG,Becenti DJ,et al.Transcriptome analysis of endothelial cell gene expression induced by growth on matrigel matrices:identification and characterization of MAGP-2 and lumican as novel regulators of angiogenesis.Angiogenesis,2007,10:197-216.
[11]
Sher I,Zisman Rozen S,Eliahu L,et al.Targeting perlecan in human keratinocytes reveals novel roles for perlecan in epidermal formation.J Biol Chem,2006,281:5178-5187.
[12]
Mongiat M,Fu J,Oldershaw R,et al.Perlecan protein core interacts with extracellular matrix protein 1(ECM1),a glycoprotein involved in bone formation and angiogenesis.J Biol Chem,2003,278:17 491-17 499.
[13]
Segade F.Molecular evolution of the fibulins:implications on the functionality of the elastic fibulins.Gene,2010,464:17-31.
[14]
Fujimoto N,Terlizzi J,Brittingham R,et al.Extracellular matrix protein 1 interacts with the domain III of fibulin-1C and 1D variants through its central tandem repeat 2.Biochem Biophys Res Commun,2005,333:1327-1333.
[15]
Sercu S,Lambeir AM,Steenackers E,et al.ECM1 interacts with fibulin-3 and the beta 3 chain of laminin 332 through its serum albumin subdomain-like 2 domain.Matrix Biol,2009,28:160-169.
[16]
Fingleton B.Matrix metalloproteinases:roles in cancer and metastasis.Front Biosci,2006,11:479-491.
[17]
Littlepage LE,Sternlicht MD,Rougier N,et al.Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis,metastasis,and angiogenesis progression.Cancer Res,2010,70:2224-2234.
[18]
Fujimoto N,Terlizzi J,Aho S,et al.Extracellular matrix protein 1 inhibits the activity of matrix metalloproteinase 9 through high-affinity protein/protein interactions.Exp Dermatol,2006,15:300-307.
[19]
侯彦强,仲人前,耿红莲,等.细胞外基质蛋白1在乳腺癌组织和细胞株中的表达及其意义.中国肿瘤生物治疗杂志,2008,15:384-387.
[20]
McPherson LA,Woodfield GW,Weigel RJ.AP2 transcription factors regulate expression of CRABPⅡin hormone responsive breast carcinoma.J Surg Res,2007,138:71-78.
[21]
Kenny PA,Enver T,Ashworth A.Receptor and secreted targets of Wnt-1/β-catenin signalling in mouse mammary epithelial cells.BMC Cancer,2005,5:3.
[22]
Du Q,Zhang X,Cardinal J,et al.Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells.Cancer Res,2009,69:3764-4771.
[23]
Lal G,Hashimi S,Smith BJ,et al.Extracellular Matrix 1(ECM1)expression is a novel prognostic marker for poor long-term survival in breast cancer:a hospital-based cohort study in Iowa.Ann Surg Oncol,2009,16:2280-2287.
[24]
Bergamaschi A,Tagliabue E,Srile T,et al.Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome.J Pathol,2008,214:357-367.
[25]
Kreunin P,Urquidi V,Lubman DM,et al.Identification of metastasis-associated proteins in a human tumor metastasis model using the mass-mapping technique.Proteomics,2004,4:2754-2765.
[26]
Wang L,Yu J,Ni J,et al.Extracellular matrix protein 1(ECM1)is overexpressed in malignant epithelial tumors.Cancer Lett,2003,200:57-67.
[27]
邵志敏.乳腺癌转移机制的研究及其临床应用.中华乳腺病杂志:电子版,2009,3:475-479.
[28]
耿翠芝.与乳腺癌相关的肿瘤标志物研究现状及评价.中华乳腺病杂志:电子版,2009,3:9-15.
[1] 河北省抗癌协会乳腺癌专业委员会护理协作组. 乳腺癌中心静脉通路护理管理专家共识[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 321-329.
[2] 刘晨鹭, 刘洁, 张帆, 严彩英, 陈倩, 陈双庆. 增强MRI 影像组学特征生境分析在预测乳腺癌HER-2 表达状态中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 339-345.
[3] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[4] 邱琳, 刘锦辉, 组木热提·吐尔洪, 马悦心, 冷晓玲. 超声影像组学对致密型乳腺背景中非肿块型乳腺癌的诊断价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 353-360.
[5] 程燕妮, 樊菁, 肖瑶, 舒瑞, 明昊, 党晓智, 宋宏萍. 乳腺组织定位标记夹的应用与进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 361-365.
[6] 涂盛楠, 胡芬, 张娟, 蔡海峰, 杨俊泉. 天然植物提取物在乳腺癌治疗中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 366-370.
[7] 朱文婷, 顾鹏, 孙星. 非酒精性脂肪性肝病对乳腺癌发生发展及治疗的影响[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 371-375.
[8] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[9] 周世振, 朱兴亚, 袁庆港, 刘理想, 王凯, 缪骥, 丁超, 汪灏, 管文贤. 吲哚菁绿荧光成像技术在腹腔镜直肠癌侧方淋巴结清扫中的应用效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 44-47.
[10] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[11] 林逸, 钟文龙, 李锴文, 何旺, 林天歆. 广东省医学会泌尿外科疑难病例多学科会诊(第15期)——转移性膀胱癌的综合治疗[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 648-652.
[12] 刘敏思, 李荣, 李媚. 基于GGT与Plt比值的模型在HBV相关肝细胞癌诊断中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 831-835.
[13] 陆镜明, 韩大为, 任耀星, 黄天笑, 向俊西, 张谞丰, 吕毅, 王傅民. 基于术前影像组学的肝内胆管细胞癌淋巴结转移预测的系统性分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 852-858.
[14] 张润锦, 阳盼, 林燕斯, 刘尊龙, 刘建平, 金小岩. EB病毒相关胆管癌伴多发转移一例及国内文献复习[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 865-869.
[15] 王曦娅, 尹弘青, 丁伟, 徐滨, 于海源, 马东升, 邵军. 桥本背景下甲状腺乳头状癌多参数分析预测大容量淋巴结转移[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 548-554.
阅读次数
全文


摘要